Download Docs
Export
Print

STEM HOLDINGS, INC.

88693646 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Nov. 15, 2019
Serial No. 88693646
Examining Attorney CAILE MAUREEN REID
Class Ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; plant-based ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; botanical ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; herbal ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; agricultural ingredients for use in the manufacture of cosmetics, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; plant-based ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive plant-based ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; plant-based ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; plant-based ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive plant-based ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; plant-based ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; botanical ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive botanical ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; botanical ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; botanical ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive botanical ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; botanical ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; herbal ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive herbal ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; herbal ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; herbal ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive herbal ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; herbal ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; agricultural ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive agricultural ingredients for use in the manufacture of pharmaceuticals, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; agricultural ingredients for use in the manufacture of pharmaceuticals, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; agricultural ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; inactive agricultural ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act; agricultural ingredients for use in the manufacture of pharmaceuticals for promoting wellness, the foregoing containing, as an inactive ingredient, CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods noncompliant with the Federal Controlled Substances Act or the Federal Food, Drug and Cosmetic Act, the foregoing not including any goods not conforming to an OTC Monograph; 001; 005; 006; 010; 026; 046; 001; 004; 006; 050; 051; 052; 001; 006; 015; 005; 006; 018; 044; 046; 051; 052; 046; 001; 046; 002; 008; 009; 017; 100; 101; 102; 100; 101; 102
STEM HOLDINGS, INC.
Case Type Trademark Service mark
Status A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additional information and/or making an initial refusal. The applicant must respond to this Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Last Updated: 2 days, 9 hours ago
Filing Date # Docket Text